Stage III or IV Melanoma
2 clinical trials · Condition
◉ Watch Stage III or IV Melanoma
| Record | Firm | Date |
|---|---|---|
| Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma (NCT02200562) | University of Utah | 2014-12-01 |
| Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma (NCT01455103) | Bristol-Myers Squibb | 2011-11-01 |
Track Stage III or IV Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.